Home

Μετασχηματιστής Χειροτερεύει ντροπή ellen m mcdonagh genomicsengland.co.uk προσθέστε στο Ερμηνεύω διαγράφω

Genomics England PanelApp
Genomics England PanelApp

People - Open Targets
People - Open Targets

Ellen McDonagh - Translational Informatics Director - Open Targets |  LinkedIn
Ellen McDonagh - Translational Informatics Director - Open Targets | LinkedIn

Genomics England PanelApp
Genomics England PanelApp

PanelApp Australia
PanelApp Australia

G2P: Using machine learning to understand and predict genes causing rare  neurological disorders | bioRxiv
G2P: Using machine learning to understand and predict genes causing rare neurological disorders | bioRxiv

People - Open Targets
People - Open Targets

6th Plenary – GA4GH
6th Plenary – GA4GH

The 100 000 Genomes Project: bringing whole genome sequencing to the NHS
The 100 000 Genomes Project: bringing whole genome sequencing to the NHS

6th Plenary – GA4GH
6th Plenary – GA4GH

Ellen McDonagh - Translational Informatics Director - Open Targets |  LinkedIn
Ellen McDonagh - Translational Informatics Director - Open Targets | LinkedIn

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care —  Preliminary Report | NEJM
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | NEJM

Genomics England PanelApp
Genomics England PanelApp

Ellen McDonagh - Translational Informatics Director - Open Targets |  LinkedIn
Ellen McDonagh - Translational Informatics Director - Open Targets | LinkedIn

G2P: Using machine learning to understand and predict genes causing rare  neurological disorders | bioRxiv
G2P: Using machine learning to understand and predict genes causing rare neurological disorders | bioRxiv

Whole genome sequencing for the diagnosis of neurological repeat expansion  disorders in the UK: a retrospective diagnostic accuracy and prospective  clinical validation study - The Lancet Neurology
Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study - The Lancet Neurology

Eleanor Williams (@williams_e_m) / X
Eleanor Williams (@williams_e_m) / X

Whole genome sequencing for the diagnosis of neurological repeat expansion  disorders in the UK: a retrospective diagnostic accuracy and prospective  clinical validation study - The Lancet Neurology
Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study - The Lancet Neurology

PanelApp Australia
PanelApp Australia

Ellen McDonagh - Translational Informatics Director - Open Targets |  LinkedIn
Ellen McDonagh - Translational Informatics Director - Open Targets | LinkedIn

Kristina IBÁÑEZ | Senior data scientist in genomics | PhD | Queen Mary,  University of London, London | QMUL | Research profile
Kristina IBÁÑEZ | Senior data scientist in genomics | PhD | Queen Mary, University of London, London | QMUL | Research profile

Genomics England PanelApp
Genomics England PanelApp

Volume 51 Issue 11, November 2019
Volume 51 Issue 11, November 2019

Arianna TUCCI | Clinical Geneticist MD PhD | MD, PhD | 100000 Genomes  Project | Research profile
Arianna TUCCI | Clinical Geneticist MD PhD | MD, PhD | 100000 Genomes Project | Research profile

People - Open Targets
People - Open Targets

A systematic CRISPR screen defines mutational mechanisms underpinning  signatures caused by replication errors and endogenous DNA damage | Nature  Cancer
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage | Nature Cancer

The 100 000 Genomes Project: bringing whole genome sequencing to the NHS |  The BMJ
The 100 000 Genomes Project: bringing whole genome sequencing to the NHS | The BMJ